Literature DB >> 17673807

Hairy cell leukemia.

Ronan Swords1, Francis Giles.   

Abstract

Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder characterized by pancytopenia and variable infiltration of the reticuloendothelial system with "hairy" lymphocytes. HCL is more common in men than women and has a median age of diagnosis of 52 yr. Typically, patients with HCL respond well to purine analog-based therapy. The purpose of this review will be to establish the current status of HCL with respect to its pathophysiology, diagnosis, management, and future directions.

Entities:  

Mesh：

Year:  2007        PMID： 17673807     DOI： 10.1007/BF02685898

Source DB:  PubMed          Journal:  Med Oncol        ISSN： 1357-0560            Impact factor:   3.064


  90 in total

Review 1.  Evolving concepts in the pathogenesis of hairy-cell leukaemia.

Authors:  Enrico Tiacci; Arcangelo Liso; Miguel Piris; Brunangelo Falini
Journal:  Nat Rev Cancer       Date:  2006-06       Impact factor: 60.716

Review 2.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

3.  Long remissions in hairy cell leukemia with purine analogs: a report of 219 patients with a median follow-up of 12.5 years.

Authors:  Monica Else; Rosa Ruchlemer; Nnenna Osuji; Ilaria Del Giudice; Estella Matutes; Anthony Woodman; Andrew Wotherspoon; John Swansbury; Claire Dearden; Daniel Catovsky
Journal:  Cancer       Date:  2005-12-01       Impact factor: 6.860

4.  Heterogeneous somatic hypermutation status confounds the cell of origin in hairy cell leukemia.

Authors:  Mia Thorsélius; Sarah H Walsh; Ulf Thunberg; Hans Hagberg; Christer Sundström; Richard Rosenquist
Journal:  Leuk Res       Date:  2005-02       Impact factor: 3.156

5.  Constitutively activated Rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells.

Authors:  Xian Zhang; Takashi Machii; Itaru Matsumura; Sachiko Ezoe; Akira Kawasaki; Hirokazu Tanaka; Shuji Ueda; Hiroyuki Sugahara; Hirohiko Shibayama; Masao Mizuki; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2003-04       Impact factor: 2.490

6.  Analysis of CD10+ hairy cell leukemia.

Authors:  Tammy M Jasionowski; Leah Hartung; Jay H Greenwood; Sherrie L Perkins; David W Bahler
Journal:  Am J Clin Pathol       Date:  2003-08       Impact factor: 2.493

7.  The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders.

Authors:  E Matutes; R Morilla; K Owusu-Ankomah; A Houlihan; D Catovsky
Journal:  Blood       Date:  1994-03-15       Impact factor: 22.113

8.  Hairy cell leukemia: a tumor of pre-plasma cells.

Authors:  K C Anderson; A W Boyd; D C Fisher; D Leslie; S F Schlossman; L M Nadler
Journal:  Blood       Date:  1985-03       Impact factor: 22.113

9.  Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine.

Authors:  G Juliusson; R Lenkei; J Liliemark
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

10.  A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.

Authors:  B Filleul; A Delannoy; A Ferrant; A Zenebergh; S Van Daele; A Bosly; C Doyen; P Mineur; P Glorieux; P Driesschaert
Journal:  Leukemia       Date:  1994-07       Impact factor: 11.528
View more
  2 in total

1.  Oral hairy leukoplakia arising in a patient with hairy cell leukaemia: the first reported case.

Authors:  Gemma Davis; Alexandra Perks; Pemith Liyanage; Konrad Staines
Journal:  BMJ Case Rep       Date:  2017-04-06

Review 2.  How I treat hairy cell leukemia.

Authors:  Michael R Grever
Journal:  Blood       Date:  2009-10-20       Impact factor: 22.113
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.